Conducting Due Diligence in the Age of “Six Feet Apart”: Strategies for Performing a Robust Virtual/Remote IP Due Diligence Review

November 9, 2020 12:45pm

Andrew K. Holmes
Patent Attorney
Novartis Pharmaceuticals (New York, NY)

Jane M. Love
Gibson, Dunn & Crutcher LLP (New York, NY)

Baldassare (Baldo) Vinti
Proskauer Rose LLP

Karthik Subramanian
Senior Product Director
PatSnap (London, United Kingdom)

Due to this year’s pandemic, many of us have had to quickly adapt to a “new normal” which relies largely on virtual and remote business operations. This panel will share strategies that life sciences companies can employ to successfully conduct virtual or remote due diligence reviews going forward.

  • Conducting a robust due diligence review from start to finish by adjusting corporate policies and procedures
  • Developing strategies for overcoming challenges relating to:»Inaccessibility to hard-copy documents and the need to share large amounts of data
    • Remote coordination of due diligence teams
    • In person meetings being moved online
    • Virtual communications among multiple parties (attorneys, BD, scientists, etc.)
  • Mitigating new risks that arise through the use of new and alternate diligence methods (e.g. cyber security risks, data security risks, etc.)